Cargando…

Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro – Implication for Drug Development

Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular models that better mimic physiologic tissues. Spheroids are one such 3D model where clusters of cells will undergo self-assembly to form viable, 3D tumor-like structures. However, to date little is known a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekert, Jason E., Johnson, Kjell, Strake, Brandy, Pardinas, Jose, Jarantow, Stephen, Perkinson, Robert, Colter, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956916/
https://www.ncbi.nlm.nih.gov/pubmed/24638075
http://dx.doi.org/10.1371/journal.pone.0092248
_version_ 1782307732401946624
author Ekert, Jason E.
Johnson, Kjell
Strake, Brandy
Pardinas, Jose
Jarantow, Stephen
Perkinson, Robert
Colter, David C.
author_facet Ekert, Jason E.
Johnson, Kjell
Strake, Brandy
Pardinas, Jose
Jarantow, Stephen
Perkinson, Robert
Colter, David C.
author_sort Ekert, Jason E.
collection PubMed
description Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular models that better mimic physiologic tissues. Spheroids are one such 3D model where clusters of cells will undergo self-assembly to form viable, 3D tumor-like structures. However, to date little is known about how spheroid biology compares to that of the more traditional and widely utilized 2D monolayer cultures. Therefore, the goal of this study was to characterize the phenotypic and functional differences between lung tumor cells grown as 2D monolayer cultures, versus cells grown as 3D spheroids. Eight lung tumor cell lines, displaying varying levels of epidermal growth factor receptor (EGFR) and cMET protein expression, were used to develop a 3D spheroid cell culture model using low attachment U-bottom plates. The 3D spheroids were compared with cells grown in monolayer for 1) EGFR and cMET receptor expression, as determined by flow cytometry, 2) EGFR and cMET phosphorylation by MSD assay, and 3) cell proliferation in response to epidermal growth factor (EGF) and hepatocyte growth factor (HGF). In addition, drug responsiveness to EGFR and cMET inhibitors (Erlotinib, Crizotinib, Cetuximab [Erbitux] and Onartuzumab [MetMab]) was evaluated by measuring the extent of cell proliferation and migration. Data showed that EGFR and cMET expression is reduced at day four of untreated spheroid culture compared to monolayer. Basal phosphorylation of EGFR and cMET was higher in spheroids compared to monolayer cultures. Spheroids showed reduced EGFR and cMET phosphorylation when stimulated with ligand compared to 2D cultures. Spheroids showed an altered cell proliferation response to HGF, as well as to EGFR and cMET inhibitors, compared to monolayer cultures. Finally, spheroid cultures showed exceptional utility in a cell migration assay. Overall, the 3D spheroid culture changed the cellular response to drugs and growth factors and may more accurately mimic the natural tumor microenvironment.
format Online
Article
Text
id pubmed-3956916
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39569162014-03-18 Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro – Implication for Drug Development Ekert, Jason E. Johnson, Kjell Strake, Brandy Pardinas, Jose Jarantow, Stephen Perkinson, Robert Colter, David C. PLoS One Research Article Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular models that better mimic physiologic tissues. Spheroids are one such 3D model where clusters of cells will undergo self-assembly to form viable, 3D tumor-like structures. However, to date little is known about how spheroid biology compares to that of the more traditional and widely utilized 2D monolayer cultures. Therefore, the goal of this study was to characterize the phenotypic and functional differences between lung tumor cells grown as 2D monolayer cultures, versus cells grown as 3D spheroids. Eight lung tumor cell lines, displaying varying levels of epidermal growth factor receptor (EGFR) and cMET protein expression, were used to develop a 3D spheroid cell culture model using low attachment U-bottom plates. The 3D spheroids were compared with cells grown in monolayer for 1) EGFR and cMET receptor expression, as determined by flow cytometry, 2) EGFR and cMET phosphorylation by MSD assay, and 3) cell proliferation in response to epidermal growth factor (EGF) and hepatocyte growth factor (HGF). In addition, drug responsiveness to EGFR and cMET inhibitors (Erlotinib, Crizotinib, Cetuximab [Erbitux] and Onartuzumab [MetMab]) was evaluated by measuring the extent of cell proliferation and migration. Data showed that EGFR and cMET expression is reduced at day four of untreated spheroid culture compared to monolayer. Basal phosphorylation of EGFR and cMET was higher in spheroids compared to monolayer cultures. Spheroids showed reduced EGFR and cMET phosphorylation when stimulated with ligand compared to 2D cultures. Spheroids showed an altered cell proliferation response to HGF, as well as to EGFR and cMET inhibitors, compared to monolayer cultures. Finally, spheroid cultures showed exceptional utility in a cell migration assay. Overall, the 3D spheroid culture changed the cellular response to drugs and growth factors and may more accurately mimic the natural tumor microenvironment. Public Library of Science 2014-03-17 /pmc/articles/PMC3956916/ /pubmed/24638075 http://dx.doi.org/10.1371/journal.pone.0092248 Text en © 2014 Ekert et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ekert, Jason E.
Johnson, Kjell
Strake, Brandy
Pardinas, Jose
Jarantow, Stephen
Perkinson, Robert
Colter, David C.
Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro – Implication for Drug Development
title Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro – Implication for Drug Development
title_full Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro – Implication for Drug Development
title_fullStr Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro – Implication for Drug Development
title_full_unstemmed Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro – Implication for Drug Development
title_short Three-Dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness In Vitro – Implication for Drug Development
title_sort three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro – implication for drug development
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956916/
https://www.ncbi.nlm.nih.gov/pubmed/24638075
http://dx.doi.org/10.1371/journal.pone.0092248
work_keys_str_mv AT ekertjasone threedimensionallungtumormicroenvironmentmodulatestherapeuticcompoundresponsivenessinvitroimplicationfordrugdevelopment
AT johnsonkjell threedimensionallungtumormicroenvironmentmodulatestherapeuticcompoundresponsivenessinvitroimplicationfordrugdevelopment
AT strakebrandy threedimensionallungtumormicroenvironmentmodulatestherapeuticcompoundresponsivenessinvitroimplicationfordrugdevelopment
AT pardinasjose threedimensionallungtumormicroenvironmentmodulatestherapeuticcompoundresponsivenessinvitroimplicationfordrugdevelopment
AT jarantowstephen threedimensionallungtumormicroenvironmentmodulatestherapeuticcompoundresponsivenessinvitroimplicationfordrugdevelopment
AT perkinsonrobert threedimensionallungtumormicroenvironmentmodulatestherapeuticcompoundresponsivenessinvitroimplicationfordrugdevelopment
AT colterdavidc threedimensionallungtumormicroenvironmentmodulatestherapeuticcompoundresponsivenessinvitroimplicationfordrugdevelopment